English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
抽象的な
The Impact of COVID-19 on Respiratory Health
Aisha FI
Respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, represent a significant public health burden worldwide. According to the World Health Organization (WHO), more than 3 million people die each year from chronic respiratory diseases, with COPD alone accounting for 3% of all deaths globally. In addition, respiratory infections, such as pneumonia, are a leading cause of death among young children and the elderly. Exposure to particulate matter, nitrogen oxides, and other pollutants can increase the risk of developing asthma, COPD, and other respiratory conditions. In addition, air pollution can worsen symptoms in people who already have these conditions, leading to more frequent and severe exacerbations. Smoking is the leading cause of preventable death worldwide, and it is also a major contributor to respiratory diseases. Smoking is responsible for approximately 90% of all cases of COPD, and it increases the risk of developing lung cancer and other respiratory conditions. Secondhand smoke is also a significant risk factor for respiratory disease, particularly in children and non-smoking adults who are exposed to smoke in their homes or workplaces.